Michael Verneris, MD
Enriched profileProfessor of Pediatrics; Director of Bone Marrow Transplantation and Cellular Therapy; Barton Family Endowed Chair of Bone Marrow Transplant · University of Colorado School of Medicine
Michael Verneris is Professor of Pediatrics; Director of Bone Marrow Transplantation and Cellular Therapy; Barton Family Endowed Chair of Bone Marrow Transplant at University of Colorado School of Medicine. OpenAlex indexes 497 publications with 23,009 citations (h-index 67); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Michael Verneris, MD, is Professor of Pediatrics at University of Colorado School of Medicine / Children's Hospital Colorado, Department of Pediatrics - Hematology/Oncology and Bone Marrow Transplantation, Anschutz Medical Campus, Aurora, CO. The public record shows 497 publications with 23,009 citations (h-index 67), centered on Kidney Cancer / RCC, Sarcoma, Lymphoma. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 10 companies, 3 NIH-funded awards (2016–2020).
- Most recent indexed publication: 2025 · Blood advances
- Top research focus: Kidney Cancer / RCC
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- T-Cell Depleted Double UCB for Refractory AML
Sponsor: Masonic Cancer Center, University of Minnesota
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Sponsor: Center for International Blood and Marrow Transplant Research
Industry payments
Updated 27 Aug 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Mesoblast, Inc.Program year20252 payments
- National Marrow Donor ProgramProgram year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2016–2020 per NIH RePORTER. The latest:
- BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases
National Marrow Donor Program
FY2026$164,412UG1HL174426 - BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases
National Marrow Donor Program
FY2025$164,548UG1HL174426 - BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases
National Marrow Donor Program
FY2024$184,489UG1HL174426
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Single-Cell RNA Sequencing of Ewing Sarcoma Tumors Demonstrates Transcriptional Heterogeneity and Clonal Evolution.
Clinical cancer research
Article2025 - Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma.
Journal for immunotherapy of cancer
Article2024
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/michael-verneris-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/michael-verneris-1b74727
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Michael-R-Verneris-40034125
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cumedicine.us ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cumedicine.us ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cumedicine.us ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdenver.edu ↗
- Board Certified
Pediatric Hematology/Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →childrenscolorado.org ↗
- Co-Director
Tumor Host Interactions Program, University of Colorado Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗ - Translational Sciences Lead
Gates Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Secondary affiliations
appointments beyond the home institution- Director-Faculty
Hematology/Oncology Division, University of Colorado Denver - Anschutz Medical Campus
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucdenver.edu ↗ - Gates Biomanufacturing Facility (Gates Institute)
CU Anschutz - collaborator on canine CAR T-cell trial with Steven Dow
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.cuanschutz.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.cuanschutz.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Abman, MD
University of Colorado School of Medicine
Daniel Pollyea, MD
University of Colorado School of Medicine
Ronald Sokol, MD
University of Colorado School of Medicine
Adriana Weinberg, MD
University of Colorado School of Medicine